TRI-LUMA 40 mg/g

TRI-LUMA 40 mg/g cream combines fluocinolone acetonide, hydroquinone, and tretinoin for topical use. This prescription medication is designed to address skin discoloration and improve skin texture. Ideal for those seeking a solution for hyperpigmentation and uneven skin tone.

TRI-LUMA 40 mg/g cream is primarily used for the treatment of moderate to severe melasma, a condition characterized by dark patches on the skin. The combination of active ingredients works to lighten dark spots and even out skin tone. This cream is often recommended for individuals looking to reduce hyperpigmentation and improve overall skin appearance.

When applied topically, TRI-LUMA 40 mg/g cream may cause initial skin irritation, redness, or dryness. These effects are typically mild and temporary as the skin adjusts to the treatment. Users should monitor their skin for any persistent or severe reactions and consult a healthcare provider if necessary.

Before using TRI-LUMA 40 mg/g cream, it is important to perform a patch test to check for any adverse reactions. Avoid applying the cream to broken or irritated skin. Pregnant or breastfeeding individuals should consult a healthcare provider before use. Keep the cream out of reach of children and store it at room temperature.

TRI-LUMA 40 mg/g cream may interact with other topical medications, particularly those containing similar active ingredients. It is advisable to avoid using other skin products unless directed by a healthcare provider. Always inform your healthcare provider about all medications you are currently using to prevent potential interactions.